Abstract
In addition to choosing appropriate medication for the treatment of patients with asthma, clinicians must also choose the best method for delivering the medication to the lungs. With recent advances in medications, an array of inhalation devices and methods are available to deliver these new medications. In addition, as more inhalation devices become available, clinicians must not only recognize the difference between types of delivery systems but also which delivery system will be optimal for each particular patient.
Keywords
Lung Deposition Inhaler Technique Inhaler Therapy Mouth Breathing Nasal Breathing
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.National Asthma Education and Prevention Program: Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. Publication no. 97–4051. Rockville, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 1995.Google Scholar
- 2.Sheth KK, Kelly HW, Mitchell BH: Innovations in Dry Powder Inhalers. CME Monograph. Bala Cynwyd, PA: Meniscus Limited; 2000.Google Scholar
- 3.Tansley I. The technical transition to CFC-free inhalers. BrJ Clin Pract 1997, 89 (suppl):22–27.Google Scholar
- 4.Ariyananda PL, Agnew JE, Clarke SW: Aerosol delivery systems for bronchial asthma. Postgrad Med J 1996, 72:151–156.PubMedCrossRefGoogle Scholar
- 5.Wolff RK, Niven RW: Generation of acrosolized drugs. Aerosol Med 1994, 7:89–106.CrossRefGoogle Scholar
- 6.Bisgaard H: Drug delivery from inhaler devices. Br MedJ1996, 313:895–896.CrossRefGoogle Scholar
- 7.Byron PR: Respiratory Drug Delivery. Edited by Byron PR. Boca Raton, FL: CRC Press Inc; 1990.Google Scholar
- 8.Schlaeppi M, Edwards K, Fuller RW, Sharma R: Patient perception of the Diskus inhaler: a comparison with the Turbuhaler inhaler. Br J Clin Pract 1996,50:14–19.PubMedGoogle Scholar
- 9.Tashkin DP: New devices for asthma. J Allergy Clin Immunol 1998, 101(suppl):409–441.CrossRefGoogle Scholar
- 10.Targeting drugs to the lung. Respir Med 1997, 91(suppl).Google Scholar
- 11.Murakami G, Igarashi T, Adachi Y, et al.: Measurement of bronchial hyperactivity in infants and preschool children using a new method. Ann Allergy 1990, 64:383–387.PubMedGoogle Scholar
- 12.Ryan G, Dolovich MB, Obminski G, et al.: Standardization of inhalation provocation tests: influence of nebulizer output, particle size and method of inhalation. J Allergy Clin Immunol 1981, 67:156–162.PubMedCrossRefGoogle Scholar
- 13.Everard ML, Clark AR, Milnar AD: Drug delivery from jet nebulizers. Arch Dis Child 1992, 67:586–591.PubMedCrossRefGoogle Scholar
- 14.Vanden Burgt JA, et al.:Efficacy and safety overview of new inhaled corticosteroid, QVAR, in asthma. J Allergy Clin Immunol 2000, 1209–1226.Google Scholar
Copyright information
© Current Medicine, Inc. 2002